Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia — Stella

Home/Preeclampsia/Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

View on ClinicalTrials.gov

Recruiting

Back to Preeclampsia trials

Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

FANG HE, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

FANG HE

Enrollment target

~1,800 participants

Started

November 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 45 Years

Sex

Female only

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.